Rigrodsky & Long, P.A.:

  • Do you, or did you, own shares of USA Technologies, Inc. (NASDAQ GM: USAT)?
  • Did you purchase your shares between September 29, 2014 and September 29, 2015, inclusive?
  • Did you lose money in your investment?

Rigrodsky & Long, P.A. reminds shareholders of USA Technologies, Inc. (“USA Technologies” or the “Company”) (NASDAQ GM: USAT) of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. A complaint was filed in the United States District Court for the Eastern District of Pennsylvania on behalf of all persons or entities that purchased the common stock of USA Technologies between September 29, 2014 and September 29, 2015, inclusive (the “Class Period”), alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its officers (the “Complaint”).

If you wish to serve as lead plaintiff, you must move the Court no later than December 1, 2015. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the proposed class may move the court to serve as lead plaintiff through counsel of their choice. One of the key factors in selecting the lead plaintiff is the size of the loss. The larger the size of your economic loss, the greater the likelihood that you may be appointed to serve as lead plaintiff. Alternatively, you may choose to do nothing and remain an absent class member.

If you purchased shares of USA Technologies during the Class Period, or purchased shares prior to the Class Period and still hold USA Technologies, and wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact Timothy J. MacFall, Esquire or Peter Allocco of Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803 at (888) 969-4242; by e-mail to info@rl-legal.com; or at: http://rigrodskylong.com/investigations/usa-technologies-inc-usat.

Attorney advertising. Prior results do not guarantee a similar outcome.